Analysts Estimate AbbVie (ABBV) to Report a Decline in Earnings: What to Look Out for
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·7h ago
More News
Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It?
According to the average brokerage recommendation (ABR), one should invest in AbbVie (ABBV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Zacks·7h ago
AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know
AbbVie (ABBV) concluded the recent trading session at $228.68, signifying a -1.17% move from its prior day's close.
Zacks·2d ago
AbbVie Up More Than 30% in 6 Months: How to Play the Stock
AbbVie's 30% surge in six months is powered by booming sales of Skyrizi and Rinvoq and renewed strength across oncology and neuroscience.
Zacks·2d ago
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Zacks·2d ago
This 3 Stocks Portfolio Provides Monthly Income
Who doesn't like payday? Investors can structure a portfolio that provides monthly income with this combination of three stocks.
Zacks·3d ago
Top Stock Reports for Apple, Meta Platforms & JPMorgan
Apple's Services surge, Meta's AI push, and JPMorgan's strong capital markets results headline today's top stock research picks.
Zacks·3d ago
Final Trades: Abbvie, Qualcomm, Aptiv, and Palo Alto Networks
The Investment Committee give you their top stocks to watch for the second half...
CNBC Television-YouTube·3d ago
The Confidence Project by BOTOX Cosmetic (onabotulinumtoxinA) Unveils This Year's Grant Recipients
The Confidence Project by BOTOX Cosmetic (onabotulinumtoxinA) Unveils This Year's Grant Recipients The Confidence Project by BOTOX Cosmetic (onabotulinumtoxinA) Unveils This Year's Grant Recipients...
PR Newswire·3d ago
Here's What to Expect From AbbVie's Oncology Segment in Q3 Earnings
ABBV's oncology lineup, spanning blood and solid tumor drugs, faces modest Q3 growth as new launches offset Imbruvica's decline.